Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, S. Hayman, T. Kourelis, R. Warsame, Y. Hwa, A. Fonder, M. Hobbs, E. Muchtar, N. Leung, P. Kapoor, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. RajkumarM. A. Gertz, A. Dispenzieri*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Article number91
JournalBlood Cancer Journal
Volume13
Issue number1
DOIs
StatePublished - Dec 2023

Funding

FundersFunder number
Predolin Foundation
National Cancer Institute
Jabbs Foundation

    Cite this